Cobalt 57 bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study

J.J. Rasker, H. Beekhuis, A.M. van de Wal, J.N. Homan van der Heide, M.G. Woldring

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
2 Downloads (Pure)

Abstract

Because the results with cobalt 57 bleomycin (57Co bleo) as a tumour seeking agent in patients with pulmonary tumours were promising, a prospective study was carried out to test the sensitivity and selectivity of this technique for metastases in lung hila and mediastinum in a group of patients with bronchial cancer. The sensitivity of 57Co bleo scintigraphy appeared to be higher than that of routine radiological investigations and mediastinoscopy. For this reason it is suggested that 57Co bleo scintigraphy can be used as a method to select patients for mediastinoscopy.

Original languageEnglish
Pages (from-to)641-649
Number of pages9
JournalThorax
Volume31
Issue number6
DOIs
Publication statusPublished - 1 Jan 1976
Externally publishedYes

Fingerprint Dive into the research topics of 'Cobalt 57 bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study'. Together they form a unique fingerprint.

  • Cite this